Skip to Content

Fluorescein sodium injection

Last Updated: May 8, 2015
Status: Resolved

Products Affected - Description

Fluorescein sodium 10% injection, Altaire Pharmaceuticals
100 mg/mL 5 mL vial, 12 count (NDC 59390-0199-05)

Fluorescein sodium 25% injection, Altaire Pharmaceuticals
250 mg/mL 2 mL vial, 12 count (NDC 59390-0200-02)

Fluorescein Lite 10% injection, Altaire Pharmaceuticals
100 mg/mL 5 mL vial, 12 count (NDC 59390-0188-05)

Fluorescein Lite 25% injection, Altaire Pharmaceuticals
250 mg/mL 2 mL vial, 12 count (NDC 59390-0187-02)

Reason for the Shortage

Altaire Pharmaceuticals temporarily discontinued fluorescein and fluorescein lite products. Altaire Pharmaceuticals could not provide a reason for the temporary discontinuation.

Available Products

AK-Fluor 10% injection, Akorn
100 mg/mL 5 mL vial, 12 count (NDC 17478-0253-10)


AK-Fluor 25% injection, Akorn
250 mg/mL 5 mL vial, 12 count (NDC 17478-0250-20)

Fluorescite 10% injection, Alcon
100 mg/mL 5 mL, 12 count (NDC 00065-0092-65)

Estimated Resupply Dates

Altaire Pharmaceuticals temporarily discontinued fluorescein and fluorescein lite vials, and the company could not estimate when product would be available.

Related Shortages

Updated

May 8, March 31, February 25, January 8, 2015; December 17 and 22, November 13, October 16, September 29, August 20, July 1, May 7 and 21, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide